Extending the hCG OPU Interval (DelOPU)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02871154|
Recruitment Status : Unknown
Verified August 2016 by The Baruch Padeh Medical Center, Poriya.
Recruitment status was: Not yet recruiting
First Posted : August 18, 2016
Last Update Posted : August 18, 2016
Our and others experience suggest that in some cases delaying oocyte pick up (OPU) for more than 39 hours after hCG injection may be of benefit.
We plan to apply this to 20 women in whom less than 20% of oocytes were found suitable for intracytoplasmic sperm injection. The delay will be for up to an interval of 47 hours from hCG to OPU.
|Condition or disease||Intervention/treatment||Phase|
|Infertility||Other: Delaying oocyte pick up beyond 39 hours post hCG||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Extending the Time Period Between the Injection of Chorionic Gonadotropin and Oocyte Pick-up as a Solution to Low Rate of Mature Oocyte and Poor Results in Assisted Reproduction|
|Study Start Date :||January 2017|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|
Delaying oocyte pick up beyond 39 hours post hCG
Other: Delaying oocyte pick up beyond 39 hours post hCG
Unlike the traditional less-than 39 hours interval from hCG injection to oocyte pick up, we will extend the interval up to 47 hours
- Conception [ Time Frame: Two years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02871154
|Contact: Izhar Ben Shlomo, MDemail@example.com|
|Contact: Johenny S Younis, MDfirstname.lastname@example.org|
|Study Director:||Odeh-L'ya Katz, PhD||Beruch Padeh Med Ctr Research Authority|